Nano-Drug Delivery for Cancer Treatment
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 2434
Special Issue Editor
Special Issue Information
Dear Colleagues,
The field of drug delivery concerned with directing and augmenting the effects of agents used in anti-neoplastic therapy has produced several technologies which are now in clinical use. As the field continues to produce useful products, research in useful materials, as well as their creation, properties, and application, will drive the next generation of therapeutics.
Stages of this development pipeline begin with creation of novel materials that can be scaled to nano-delivery systems, or with the re-application of established systems engineered with novel mechanisms to improve their application to a wider range of payloads or targets. The next stage of the pipeline explores the therapeutic properties of these delivery systems when they specifically accumulate in a targeted cancer environment, or the side effects when they non-specifically accumulate in off-target sites. The final stage of the pipeline explores the overall therapeutic efficacy of these delivery systems—either front-line, or in disease that has no established treatment. The aim of this Special Issue is to celebrate work in development through all stages of this development pipeline in the form of original research or review articles.
Dr. Jason S. Buhrman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- drug delivery
- selective accumulation
- payload release
